Journals / Bozok Tıp Dergisi / 2014 / Cilt: 4 - Sayı: 3

Effectiveness of Nifedipine in Management of Preterm Labor

PRETERM EYLEM TEDAVİSİNDE NİFEDİPİN'İN ETKİNLİĞİ

Pages
41–47
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There were no statistically difference in between two groups for age, body mass index,gravidity, parity, cervical lenght at time of admission, Bishop score and the mean gestational age (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim is to determine the effectiveness of nifedipine as a tocolytic in woman with pretermlabor and to determine the factors to prolong pregnancy.
📊
Key Findings & Data:Material and Methods: 112 woman in 24-37 weeks gestation who were admitted to Suleymaniye BirthAnd Women Health Education And Research Hospital and hospitalized to take nifedipine as tocolyticfrom january 2007 to 2011 december were added to our study.
💡
Conclusion & Impact:Results: There were no statistically difference in between two groups for age, body mass index,gravidity, parity, cervical lenght at time of admission, Bishop score and the mean gestational age (p
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Our aim is to determine the effectiveness of nifedipine as a tocolytic in woman with pretermlabor and to determine the factors to prolong pregnancy. Material and Methods: 112 woman in 24-37 weeks gestation who were admitted to Suleymaniye BirthAnd Women Health Education And Research Hospital and hospitalized to take nifedipine as tocolyticfrom january 2007 to 2011 december were added to our study. Partisipants were diveded into twogroups according to their delay in timing of birth: Less than seven days and lonfer than seven days.These groups were compared on the basis of their demographical feature,nenotal and maternal follow- up results. Results: There were no statistically difference in between two groups for age, body mass index,gravidity, parity, cervical lenght at time of admission, Bishop score and the mean gestational age (p

Özet

Amaç: Preterm eylem tedavisinde tokolitik olarak nifedipin kullanılan hastaların sonuçları incelenereknifedipinin etkinliği ve doğumun geciktirilmesinde katkısı olabilecek faktörleri belirlemeyi amaçladık.Gereç ve Yöntemler: Çalısmaya Ocak 2007- Aralık 2011 tarihleri arasında Süleymaniye Doğum ve Ka- dın Hastalıkları Eğitim Hastanesinde preterm eylem tanısıyla hospitalize edilen ve nifedipin ile tokolitiktedavi alan, 24-37 haftalar arasındaki 112 gebe dahil edildi. Çalışmaya dahil edilen hastalar doğumungeciktirildiği gün sayısına göre 7 gün veya daha az geciktirilenler ve 7 günden daha fazla geciktirilenlerolmak üzere iki gruba ayrılarak her iki grup demografik özellikler ile perinatal, neonatal ve maternalsonuçlar açısından karşılaştırıldı. Bulgular: Her iki grup arasında yaş, vücut kitle indeksi, gravida, parite, başvuru anındaki servikal kanaluzunluğu, Bishop skoru, tanı anındaki ortalama gebelik haftaları açısından istatistiksel olarak anlam- lı farklılık gözlenmedi (p7 gün olangrupta, sezaryen doğum oranı istatistiksel olarak anlamlı derecede daha düşük olarak bulundu (%61,8& %34,6, p=0,008). Neonatal komplikasyonlar açısında gruplar karşılaştırıldığında 7 gün ve daha az do- ğumun geciktirildiği grupta respiratuar distres sendromu ve yoğun bakım ihtiyacı istatistiksel olarak an- lamlı derecede daha yüksek olarak tespit edildi (sırasıyla p=0,017; p=0,036). Sonuç: Ciddi maternal ve fetal yan etkilerinin olmaması ve oral kullanıma uygun olması nedeniyle to- kolitik olarak nifedipinlerin kullanımı giderek artmıştır. Ancak nifedipinlerin etkinliğine yönelik yeterliplasebo kontrollü klinik çalışmalar ve ideal rejim bulunmamaktadır.

🔖

Cite This Article

ÖZDEMİR, Ö., KILIÇ, N., YÜCEL, O., BAŞER, H. C., DEMİRCAN, F., EKMEZ, F. (2022). Effectiveness of Nifedipine in Management of Preterm Labor. Bozok Tıp Dergisi, Cilt: 4 - Sayı: 3, 41–47. https://ajindex.com/articles/468936

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. van Vliet EO, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, et al. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial). BMC Pregnancy Childbirth. 2014 Mar 3;14:93. doi: 10.1186/1471-2393-14-93
  2. Kara M, Yılmaz E, Avcı İ, Öge T. Comparison of nifedipine with magnesium sulphate plus terbutaline for treatment of preterm labor. J Turk Soc Obstet Gynecol. 2009; 6(4): 250- 6
  3. Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network metaanalysis. BMJ. 2012 Oct 9;345:e6226. doi: 10.1136/bmj.e6226
  4. Conde-Agudelo A, Romero R, Kusanovic JP. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011 Feb;204(2):134. e1-20. doi: 10.1016/j.ajog.2010.11.038
  5. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev. 2003;(1):2255
  6. Ferguson JE, Schutz T, Pershe R, Stevenson DK, Blaschke T. Nifedipine pharmacokinetics during preterm labor tocolysis. Am J Obstet Gynecol. 1989;161(6):1485-90
  7. Papatsonis D, Flenady V, Liley H. Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour. Cochrane Database Syst Rev. 2009;21(1):5938
  8. Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2004;18(4):4352
  9. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002;(4):1060
  10. King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;18(2):1992
  11. Ulmsten U, Anderson KE, Wingerup L. Treatment of premature labor with the calsium antagonist nifedipine. Arch Gynecol. 1980; 229(1): 1-5
  12. Kıng JF, Fledany V, Papasonis DN, Dekker G, Carbonne B. Calcium channel blokers for inhibiting preterm labor; a systematic review of the evidence and a protocol for administration of nifedipine. Aus and New Zealand J Obstet Gynecol. 2003;43(3): 192-8
  13. Tsatsaris V, Papatsonis DN, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonist: A meta-analysis. Obstet Gynecol. 2001;97(5 Pt 2):840-7
  14. Kacmar J, Bhimani L, Boyd M, Shah-